These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1015 related items for PubMed ID: 9019768

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. [Significance of mycobacterial drug resistance in pulmonary tuberculosis surgery].
    Repin IuM, Avetisian AO, El'kin AV, Otten TF, Riasnianskaia TE, Trofimov MA.
    Probl Tuberk; 2001; (9):6-10. PubMed ID: 11858098
    [Abstract] [Full Text] [Related]

  • 43. [Drug resistance of Mycobacterium tuberculosis and its significance in the hospital practice].
    Rudoĭ NM.
    Probl Tuberk; 1996; (3):6-8. PubMed ID: 8754863
    [Abstract] [Full Text] [Related]

  • 44. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 45. [Efficiency of retrosternal lymphotropic chemotherapy in the treatment of new cases of destructive pulmonary tuberculosis].
    Kibrik BS, Zakharov AV.
    Probl Tuberk Bolezn Legk; 2009 Oct; (4):23-7. PubMed ID: 19514450
    [Abstract] [Full Text] [Related]

  • 46. [New technologies in the determination of drug susceptibility in Mycobacterium tuberculosis].
    Skotnikova OI, Mikhaĭlovich VM, Nosova EIu, Lapa SA, Griadunov DA, Donnikov MIu, Badleeva MV, Galkina KIu, Dorozhkova IR, Litvinov VI, Zasedatelev AS, Moroz AM, Mirzabekov AD.
    Probl Tuberk Bolezn Legk; 2004 Oct; (6):40-2. PubMed ID: 15315132
    [Abstract] [Full Text] [Related]

  • 47. Drug-resistant tuberculosis: resistance mechanisms and rapid susceptibility testing.
    Pfyffer GE.
    Schweiz Med Wochenschr; 2000 Dec 09; 130(49):1909-13. PubMed ID: 11153397
    [Abstract] [Full Text] [Related]

  • 48. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
    Park IN, Hong SB, Oh YM, Kim MN, Lim CM, Lee SD, Koh Y, Kim WS, Kim DS, Kim WD, Shim TS.
    J Antimicrob Chemother; 2006 Sep 09; 58(3):701-4. PubMed ID: 16857689
    [Abstract] [Full Text] [Related]

  • 49. [Drug resistant pulmonary tuberculosis: problems of diagnosis and treatment in hospital conditions].
    Suslov VA, Moskalenko VA.
    Voen Med Zh; 2002 May 09; 323(5):26-30, 112. PubMed ID: 12073833
    [Abstract] [Full Text] [Related]

  • 50. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
    Ratsirahonana O, Rasolofo Razanamparany V, Rasolonavalona T, Rakotonirina V, Rakotoarisaonina A, Rakotoherisoa A, Ralamboson M, Cauchoix B, Rakotondramarina D, Ramarokoto H.
    Arch Inst Pasteur Madagascar; 2002 May 09; 68(1-2):44-7. PubMed ID: 12643091
    [Abstract] [Full Text] [Related]

  • 51. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep 09; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 52. [Pulmonary tuberculosis. 2. Therapy].
    Bölcskei P.
    Fortschr Med; 1983 Jun 16; 101(23):1075-80, 1090. PubMed ID: 6411560
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. [New cases of pulmonary tuberculosis treatment within DOTS strategy].
    Zhangireev AA, Ismailov ShSh, Berikova EM.
    Probl Tuberk; 2000 Jun 16; (3):23-5. PubMed ID: 10900979
    [Abstract] [Full Text] [Related]

  • 56. Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance.
    Cox HS, Niemann S, Ismailov G, Doshetov D, Orozco JD, Blok L, Rüsch-Gerdes S, Kebede Y.
    Clin Infect Dis; 2007 Jun 01; 44(11):1421-7. PubMed ID: 17479936
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. [A study on the implementation of primary chemotherapy to pulmonary tuberculosis with positive bacillus].
    Tian XZ, Wang LX.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Aug 01; 16(4):220-2. PubMed ID: 7585902
    [Abstract] [Full Text] [Related]

  • 59. [Th 13-14 and PZA and CS in the treatment of chronic cavitary tuberculosis with bacterial resistance to classic antibacterial drugs].
    Zunić D.
    Tuberkuloza; 1966 Aug 01; 18(5):429-40. PubMed ID: 16296047
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.